[HTML][HTML] Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

AAT Naqvi, K Fatima, T Mohammad, U Fatima… - … et Biophysica Acta (BBA …, 2020 - Elsevier
The sudden emergence of severe respiratory disease, caused by a novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently become a public health …

COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese–Western medicine for the …

KW Chan, VT Wong, SCW Tang - The American journal of Chinese …, 2020 - World Scientific
As of 22 February 2020, more than 77662 cases of confirmed COVID-19 have been
documented globally with over 2360 deaths. Common presentations of confirmed cases …

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

M Kandeel, M Al-Nazawi - Life sciences, 2020 - Elsevier
Abstract Aims In December 2019, the Coronavirus disease-2019 (COVID-19) virus has
emerged in Wuhan, China. In this research, the first resolved COVID-19 crystal structure …

Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19

JS Khalili, H Zhu, NSA Mak, Y Yan… - Journal of medical …, 2020 - Wiley Online Library
Confronting the challenge of the outbreak of COVID‐19 should sharpen our focus on global
drug access as a key issue in antiviral therapy testing. The testing and adoption of effective …

Current epidemiological and clinical features of COVID-19; a global perspective from China

H Tu, S Tu, S Gao, A Shao, J Sheng - The COVID-19 reader, 2020 - taylorfrancis.com
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and represents a potentially fatal disease of great global public …

One year update on the COVID-19 pandemic: Where are we now?

SK Mishra, T Tripathi - Acta tropica, 2021 - Elsevier
We are living through an unprecedented crisis with the rapid spread of the new coronavirus
disease (COVID-19) worldwide within a short time. The timely availability of thousands of …

Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019

A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …

Drug development and medicinal chemistry efforts toward SARS‐coronavirus and Covid‐19 therapeutics

AK Ghosh, M Brindisi, D Shahabi… - …, 2020 - Wiley Online Library
The COVID‐19 pandemic caused by SARS‐CoV‐2 infection is spreading at an alarming
rate and has created an unprecedented health emergency around the globe. There is no …

An overview of severe acute respiratory syndrome–coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy

T Pillaiyar, M Manickam, V Namasivayam… - Journal of medicinal …, 2016 - ACS Publications
Severe acute respiratory syndrome (SARS) is caused by a newly emerged coronavirus that
infected more than 8000 individuals and resulted in more than 800 (10–15%) fatalities in …

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus

SR Weiss, S Navas-Martin - Microbiology and molecular biology …, 2005 - Am Soc Microbiol
Coronaviruses are a family of enveloped, single-stranded, positive-strand RNA viruses
classified within the Nidovirales order. This coronavirus family consists of pathogens of …